Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ACST | US
-0.07
-2.04%
Healthcare
Biotechnology
30/06/2024
17/10/2024
3.28
3.37
3.37
3.26
Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104 an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102 an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101 a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Laval Canada.
View LessValue Stock (Price to Book < 3)
Microcap (<300M USD)
High Market Beta (> 0.8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
61.4%1 month
83.0%3 months
67.7%6 months
59.6%-
-
0.58
-
-
-0.56
5.50
-
-13.27M
33.28M
33.28M
-
-
-
-
-18.56
3.26
1.61
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.49
Range1M
0.94
Range3M
1.37
Rel. volume
0.28
Price X volume
36.10K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Lantern Pharma Inc. | LTRN | Biotechnology | 3.39 | 36.49M | -3.14% | n/a | 0.71% |
Enlivex Therapeutics Ltd | ENLV | Biotechnology | 1.63 | 34.89M | -3.55% | n/a | 2.92% |
QNCX | QNCX | Biotechnology | 0.7929 | 34.31M | -3.19% | n/a | 30.62% |
OKYO Pharma Limited | OKYO | Biotechnology | 1.01 | 34.17M | -3.81% | n/a | -107.88% |
OCUP | OCUP | Biotechnology | 1.27 | 33.54M | -0.78% | n/a | 0.00% |
Moolec Science SA Ordinary Shares | MLEC | Biotechnology | 0.89 | 33.34M | -3.26% | n/a | 209.19% |
Dyadic International Inc | DYAI | Biotechnology | 1.13 | 33.31M | -2.59% | n/a | 175.64% |
Acurx Pharmaceuticals Inc. Common Stock | ACXP | Biotechnology | 2.02 | 32.82M | -1.46% | n/a | 0.00% |
Curis Inc | CRIS | Biotechnology | 5.34 | 31.93M | 0.56% | n/a | -6039.91% |
Longeveron Inc. Class A Common Stock | LGVN | Biotechnology | 2.21 | 31.73M | 10.50% | n/a | 11.72% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.56 | 0.53 | Cheaper |
Ent. to Revenue | 5.50 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 0.58 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 67.74 | 72.92 | Par |
Debt to Equity | - | -1.24 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 33.28M | 3.78B | Emerging |